Table 1: Participant characteristics ( 𝑛 = 2 4 ).

VariableAllWomen ( 𝑛 = 1 3 )Men ( 𝑛 = 1 1 )

Age, yrs 7 8 ± 1 7 7 ± 1 8 0 ± 1
Body mass index, kg/m2 2 6 ± 1 2 6 ± 1 2 6 ± 1
Systolic blood pressure, mmHg 1 3 0 ± 3 1 3 0 ± 4 1 3 0 ± 4
Diastolic blood pressure, mmHg 7 4 ± 1 7 4 ± 3 7 5 ± 3
Mean arterial pressure, mmHg 9 3 ± 2 9 4 ± 2 9 3 ± 2
Heart rate, bpm 6 2 ± 2 6 3 ± 3 6 1 ± 2
Total cholesterol, mg/dL 1 7 7 ± 6 1 8 4 ± 8 1 6 3 ± 1 0
LDL cholesterol, mg/dL 1 0 5 ± 4 1 0 9 ± 6 1 0 0 ± 8
HDL cholesterol, mg/dL 5 4 ± 3 5 8 ± 3 4 6 ± 4
Triglycerides, mg/dL 9 6 ± 9 1 0 7 ± 1 6 8 4 ± 5
Glucose, mg/dL 9 3 ± 2 9 4 ± 3 9 2 ± 3
White blood cell count 5 . 0 ± 0 . 3 5 . 2 ± 0 . 4 4 . 9 ± 0 . 3
Neutrophil/lymphocyte ratio 1 . 9 ± 0 . 1 1 . 8 ± 0 . 2 2 . 0 ± 0 . 2
Hyperlipidemia, %333136
Hypertension, %503862
Medications, %
 Aspirin333136
 ACE inhibitor261536
 Beta-blocker251831
 Calcium channel blocker17827
 Diuretic252327
 Statin333136
Leg press 1 RM 1 2 3 7 ± 7 7 1 0 4 0 ± 7 6 1 4 7 0 ± 1 0 7
Leg press peak power 40% 1 RM 4 1 7 ± 3 0 3 5 1 ± 3 3 4 9 1 ± 4 6
SPPB, score 8 . 5 ± 0 . 5 8 . 3 ± 0 . 4 8 . 9 ± 0 . 3
Physical activity, counts 9 3 2 2 4 ± 1 4 4 6 5 1 0 3 0 7 2 ± 2 2 7 6 6 8 1 5 8 6 ± 1 7 0 2 3
Brachial FMD, % 7 . 5 ± 0 . 8 8 . 8 ± 1 . 0 7 . 1 ± 1 . 0
PWA-RHI, % 2 . 1 ± 0 . 2 2 . 3 ± 0 . 1 1 . 8 ± 0 . 3
AIx, % 4 0 ± 3 4 6 ± 3 3 5 ± 3

*Significant group difference, 𝑃 < 0 . 0 5 .